ANTIKÖRPERFORMULIERUNG

Patent europeic · EP2858671 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2858671
Numer da la dumonda
EP13744818
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
11-06-2013
Publitgà
15-04-2015
Concedì
24-07-2019
La protecziun finescha il pli tard
10-06-2033
Proxima taxa annuala scadenta
30-06-2027
Classas IPC
A61K 39/395 (2006.01)
A61K 9/00 (2006.01)
A61K 47/18 (2017.01)
A61K 47/26 (2006.01)
C07K 16/28 (2006.01)
Prioritad
US 201261658472 P 12.06.2012
Dumonda PCT
PCT/IB2013/054777 11.06.2013
Publicaziun PCT
WO2013/186700 19.12.2013
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-07-2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. 01-07-2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  3. 01-07-2024

    Midada

    Published in Swissreg on 01.07.2024

  4. 01-07-2023

    Midada

    Published in Swissreg on 01.07.2023

  5. 01-07-2022

    Midada

    Published in Swissreg on 01.07.2022

  6. 24-07-2019

    Concedì

    Published in Swissreg on 24.07.2019

Partidas

Possessur

Novartis AG

Lichtstrasse 35, 4056 Basel

Inventur

STARK, Christoph

4002 Basel

COSENZA, Marta

4002 Basel

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.